Vera Bradley (VRA) Company Overview

RINCON, Puerto Rico--(BUSINESS WIRE)--Fund 1 Investments LLC (together with its affiliates, “Fund 1”) is the largest shareholder of Vera Bradley, Inc. (NASDAQ: VRA) ("Vera Bradley" or the "Company"), beneficially owning 10.0% of the Company's outstanding shares and having economic exposure of 20.0% of the outstanding shares. Today, Fund 1 sent the below letter to the Company's Board of Directors: December 30, 2024 Vera Bradley, Inc. 12420 Stonebridge Road Roanoke, Indiana 46783 Attention: Rober.

Vera Bradley, Inc. (NASDAQ:VRA ) Q3 2025 Results Conference Call December 11, 2024 9:30 AM ET Company Participants Mark Dely - Chief Administrative Officer Jackie Ardrey - Chief Executive Officer Michael Schwindle - Chief Financial Officer Conference Call Participants Eric Beder - SCC Research Daniel Harriman - Sidoti & Company Operator Greetings. Welcome to the Vera Bradley Third Quarter Fiscal 2025 Earnings Conference Call.

Vera Bradley (VRA) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of $0.06. This compares to earnings of $0.19 per share a year ago.

FORT WAYNE, Ind., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced that it plans to report results for the third quarter ending November 2, 2024 of fiscal year 2025 at 8:00 a.m. Eastern Time on Wednesday, December 11, 2024.

FORT WAYNE, Ind., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (“Vera Bradley” or the “Company”) (NASDAQ:VRA) today announced the appointment of Ian Bickley to its Board of Directors (the “Board”) effective November 1, 2024.

FORT WAYNE, Ind., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) announced today that the Board of Directors of the Company (the “Board”) unanimously approved the adoption of a limited duration shareholder rights plan (the “Rights Plan”) to protect shareholders' interests and maximize value for all shareholders.

Vera Bradley's 2Q25 results were disappointing, with significant sales and gross margin declines, and guidance slashed from $21 million to $3 million in operating income. The company's abrupt rebranding has faced severe backlash from core customers, leading to concerns about future demand and customer loyalty. Despite historical valuation metrics suggesting a cheap stock, the uncertainty surrounding the new branding and product changes makes it difficult to assess Vera Bradley's true value.

FORT WAYNE, Ind., Sept. 15, 2024 (GLOBE NEWSWIRE) -- The Vera Bradley Foundation for Breast Cancer (the "Foundation") today announced a donation of $1,601,830 to support the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine (“IU School of Medicine”). With this gift, the Foundation's cumulative contributions to breast cancer research now stand at $41.7 million.

Vera Bradley, Inc. (NASDAQ:VRA ) Q2 2025 Earnings Conference Call September 11, 2024 9:30 AM ET Company Participants Mark Dely - Chief Administrative Officer Jackie Ardrey - Chief Executive Officer Michael Schwindle - Chief Financial Officer Conference Call Participants Daniel Harriman - Sidoti & Company Doug Lane - Water Tower Research Eric Beder - SCC Research Operator Greetings. Welcome to the Vera Bradley Second Quarter Fiscal 2025 Earnings Conference Call.